- POSITIVE
Annual Revenue Amkay Products Mar-2026 Annual Revenue is Rs 43 Cr which is growth of 7.5% YoY.
- NEGATIVE
Annual Net Profit Amkay Products Mar-2026 Annual Net Profit is Rs 2 Cr which is growth of -30.8% YoY.
aboutAmkay Products Ltd. is an Indian company primarily engaged in the manufacturing and trading of medical devices and disposables. The company provides a range of healthcare products used in hospitals, clinics, and home care environments. It operates in... Read More
53.000.00(0.00%)
2,000
BSE Volume
BSE 27 Oct, 2026 3:31 PM (IST)
Please subscribe to view forecaster data
Amkay Products Stock Price Analysis
Month Price Range-26.8% 1 Month return | 53 (LTP) 50.876 LowHigh |
|---|---|
52 Week Price Range12.8% 1 Year return | 53 (LTP) 4382 LowHigh |
Competitors/Peers
Revenue Mix
Annual
Balance Sheet
Ratios
Cash Flow
Documents
Amkay Products annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 |
|---|---|---|---|---|---|---|---|---|---|
14.7% | 1% | 42.7 | 39.7 | 32.3 | 28.3 | 36.8 | 40.7 | ||
Operating Exp. Ann. | 15.6% | 1.1% | 38.2 | 34.3 | 27.7 | 24.7 | 33.9 | 36.1 | |
Operating Profit Ann. | 8% | -3.2% | 3.9 | 4.1 | 3.3 | 3.1 | 2.7 | 4.6 | |
OPM Ann. % | -6.7% | -4.4% | 9.01% | 10.39% | 10.30% | 11.10% | 7.22% | 11.26% | |
15.1% | 1.6% | 39.5 | 35.4 | 28.8 | 25.9 | 34.8 | 36.5 | ||
EBITDA Ann. | 8.7% | -0.4% | 4.5 | 5.4 | 4.6 | 3.5 | 3 | 4.6 | |
EBITDA Ann. margin % | -5.3% | -1.3% | 10.58% | 13.71% | 14.17% | 12.47% | 8.01% | 11.31% | |
Interest Ann. | -7.2% | 32% | 0.4 | 0.3 | 0.5 | 0.5 | 0.4 | 0.1 | |
Depr. | 8.7% | 24.6% | 0.9 | 0.8 | 0.6 | 0.7 | 0.5 | 0.3 | |
PBT Ann. | 11.6% | -5.3% | 3.2 | 4.3 | 3.5 | 2.3 | 2 | 4.2 | |
Tax Ann. | 4% | -3.9% | 0.9 | 1 | 0.9 | 0.8 | 0.6 | 1.1 | |
15.3% | -5.8% | 2.3 | 3.3 | 2.6 | 1.5 | 1.5 | 3.1 | ||
Net Profit Ann. | 15.3% | -5.8% | 2.3 | 3.3 | 2.6 | 1.5 | 1.5 | 3.1 | |
NPM Ann. % | 0.5% | -6.5% | 5.49% | 8.69% | 8.46% | 5.41% | 4.01% | 7.68% | |
EPS Adj. latest Ann. | 16.7% | -5.6% | 2.7 | 3.9 | 3 | 1.7 | 1.7 | 3.6 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
7.6%
2Y CAGR
15%
3Y CAGR
14.7%
5Y CAGR
1%
Total Revenue Annual growth is stable compared to historical averages.
Net Profit Ann.
1Y CHG
-30.3%
2Y CAGR
-5.9%
3Y CAGR
15.3%
5Y CAGR
-5.8%
Net Profit Annual is falling faster than historical averages.
Operating Exp. Ann.
1Y CHG
11.4%
2Y CAGR
17.4%
3Y CAGR
15.6%
5Y CAGR
1.1%
Operating Expenses Annual Cr growth is stable compared to historical averages.
Amkay Products Technical Analysis
Amkay Products EMA & SMA
Bearish-8
0 bullish, 8 bearish
Bullish0
Bearish8
| 5 Day | 55.1 |
|---|---|
| 10 Day | 58.4 |
| 12 Day | 59.1 |
| 20 Day | 60.2 |
| 26 Day | 60.1 |
|---|---|
| 50 Day | 59.0 |
| 100 Day | 58.0 |
| 200 Day | 57.7 |
Amkay Products Delivery And Volume
Daily Avg. Delivery Volume %
27 Oct, 2026100.0%
Week-
Month-
Amkay Products Active Candlesticks
Short Line Uptrend
Legend
Positive IndicatorNeutral IndicatorNegative Indicator
Amkay Products Resistance and Support
53.00
Pivot
| First Resistance | 53 |
|---|---|
| Second Resistance | 53 |
| Third Resistance | 53 |
| First Support | 53 |
|---|---|
| Second Support | 53 |
| Third Support | 53 |
| Day RSI | 39.2 |
|---|---|
| Day MACD | -1 |
| Day MFI | 40.3 |
| Day MACD Signal Line | 1.3 |
Amkay Products Beta
| 1 Month | 0.6 |
|---|---|
| 1 Year | 0.0 |
| 3 Month | -0.1 |
|---|---|
| 3 Year | - |
Amkay Products Price Change Analysis
↓-26.8%
Over 1 Month
LowHigh
50.876.0
↑10.4%
Over 3 Months
LowHigh
4376
↓-4.6%
Over 6 Months
LowHigh
4376
↑12.8%
Over 1 Year
LowHigh
4382.0
Amkay Products Deals - Insider, Bulk, Block and SAST
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| BHAVNA BHARAT THACKER | Bulk | Purchase | 16 Dec 2025 | 73.34 | 108,000 | BSE |
| VIJITH NARAYANAN MENON | Bulk | Purchase | 24 Jun 2025 | 55.91 | 98,000 | BSE |
| RAJSHRI CHOUDHARY | Bulk | Sell | 27 Mar 2025 | 36.41 | 44,000 | BSE |
| SANJAY POPATLAL JAIN | Bulk | Purchase | 09 Aug 2024 | 79 | 90,000 | BSE |
| AMRUTLAL GORDHANDAS THOBHANI | Bulk | Purchase | 09 Aug 2024 | 79 | 44,000 | BSE |
| VISIONARY VALUE FUND | Bulk | Sell | 09 Aug 2024 | 79 | 182,000 | BSE |
| VISIONARY VALUE FUND | Bulk | Sell | 11 Jun 2024 | 75 | 100,000 | BSE |
| SANJAY POPATLAL JAIN | Bulk | Purchase | 11 Jun 2024 | 74.99 | 72,000 | BSE |
| MERU INVESTMENT FUND PCC-CELL 1 | Bulk | Sell | 07 Jun 2024 | 58.18 | 54,000 | BSE |
| MOUNTAIN VENTURES | Bulk | Sell | 17 May 2024 | 96.98 | 96,000 | BSE |
Amkay Products Corporate Actions
Amkay Products Board Meetings
Amkay Products past and upcoming board meetings.
#Ex-Date | Purpose | Notes |
|---|---|---|
128 May 2026 | Audited Results | - |
212 Nov 2025 | Half Yearly Results | - |
323 May 2025 | Audited Results | - |
429 Nov 2024 | Half Yearly Results | - |
529 May 2024 | Audited Results | - |
Amkay Products Corporate Filings
Amkay Products BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.
| Date | Announcement Title | Details | Links |
|---|---|---|---|
| 08 Oct 2026 | Amkay Products Ltd - 544169 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | Certificate under Reg. 74(5) of SEBI LODR Reg. 2018 | |
| 03 Oct 2026 | Amkay Products Ltd - 544169 - Clarification On Price Movement As Sought By BSE | Clarification on Price Movement as sought by BSE | |
| 01 Oct 2026 | Amkay Products Ltd - 544169 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report | Scrutiniser Report of AGM | |
| 01 Oct 2026 | Amkay Products Ltd - 544169 - Clarification sought from Amkay Products Ltd | The Exchange has sought clarification from Amkay Products Ltd on October 01, 2026, with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded. The reply is awaited. | |
| 30 Sep 2026 | Amkay Products Ltd - 544169 - Shareholder Meeting / Postal Ballot-Outcome of AGM | Outcome of AGM |
Amkay Products - Company Profile
Amkay Products Management Structure
Amkay Products management structure with salaries, total experience, and qualifications.
Amkay Products Board of Directors
Amkay Products Board of directors with salaries, total experience, and qualifications.
Website: www.amkayproducts.com
About the company - Business Profile
Amkay Products Ltd. is an Indian company primarily engaged in the manufacturing and trading of medical devices and disposables. The company provides a range of healthcare products used in hospitals, clinics, and home care environments. It operates in the medical consumables segment, catering to both domestic and international markets with certifications such as ISO 13485:2016 and CE.
Key Points
Key Facts
- Founded Year: 2007 (Initially as Amkay Products Private Limited; converted to a public limited company later).
- Headquarters: Thane (Vasai), Maharashtra.
- Listing: The company is listed on the BSE SME platform (Scrip Code: 544169).
- Primary Products: Medical disposables, surgical products, and diagnostic equipment.
Operations and Resources
- Manufacturing Facility: The registered office and manufacturing unit are located at Amkay Enclave, Dhumal Nagar, Waliv Road, Vasai (East), Palghar, Maharashtra.
- Integration: The company manages a mix of self-manufactured products and traded goods. As of the half-year ended September 2025, the cost of materials consumed (manufacturing) was ₹550.55 lakhs, while the purchase of stock-in-trade (trading) was ₹858.30 lakhs.
- Quality Standards: The facilities maintain ISO 13485:2016 certification for medical devices and CE marking for specific product categories to ensure compliance with healthcare safety regulations.
Market Significance
- Industry Role: Acts as a supplier of essential medical consumables, which saw significant strategic importance during and post-pandemic periods.
- Customer Base: Serves hospitals, nursing homes, and retail pharmacies. The brand positioning is reflected in its tagline, Your Partner in Healthcare.
Business Model and Financial Performance
- Model: Amkay utilizes a hybrid model of manufacturing and distribution. It leverages its own production capacity for core disposables while trading high-demand medical equipment to maintain a comprehensive product portfolio.
- Revenue Breakdown (FY25 - Audited):
- Total Revenue from Operations: ₹3,839.01 lakhs.
- Other Income: ₹131.83 lakhs.
- Total Revenue: ₹3,970.84 lakhs.
- Revenue for H1 FY26 (Ended Sept 30, 2025): ₹2,301.14 lakhs, representing growth compared to ₹1,783.82 lakhs in H1 FY25.
- Profitability (FY25):
- Profit Before Tax (PBT): ₹429.74 lakhs.
- Profit After Tax (PAT): ₹333.44 lakhs.
- Geographical Reach: While primarily focused on the domestic Indian market, the company’s certifications allow for export opportunities in the disposables segment.
Strategic Initiatives and Future Outlook
- Capital Management: As of September 30, 2025, the company had a Net Worth of ₹2,603.31 lakhs (including Share Capital of ₹865.56 lakhs and Reserves of ₹1,737.75 lakhs).
- Expansion: Current focus remains on scaling its distribution network and increasing the volume of traded medical equipment, as evidenced by the higher expenditure on stock-in-trade compared to raw material consumption in recent periods.
- Automation: The company aims to improve manufacturing efficiency in its Palghar facility to reduce manual intervention in the production of sterile disposables.
Human Resources
- Employee Count: The company operates with a workforce of approximately 60 - 80 employees across manufacturing and administrative roles (estimated based on employee benefit expenses of ₹297.02 lakhs for FY25).
- Leadership: Managed by Kashyap Pravin Mody, who serves as the Managing Director and Chairman.
References